Press releases
Prime Therapeutics welcomes Christine Bent as new chief operating officer
Bent will lead Prime’s efforts to create the PBM of the future, working with the nation’s leading Blues plans to put caregivers and patients in a position to optimize health through advances in pharmacy management
December 2, 2019Bent comes to Prime after serving as senior vice president of operations at Allina Hospital and Clinics, one of Minnesota’s leading not-for-profit health care systems. While there, she was responsible for the operational leadership of Allina’s primary and specialty care services, integrated specialists and related sites of care, as well as 90 clinics and 10 clinical service lines representing 10,000 staff members. Prior to that, she held executive operational roles at Minnesota-based Minneapolis Heart Institute and Atrius Health in Massachusetts.
“We are extremely fortunate to have Christine join Prime at a time when our industry and health care in general are undergoing major transformation,” said Ken Paulus, president and CEO of Prime. “Her in-depth knowledge of the health care industry and more than 25 years’ experience overseeing complex health care operations make her a great fit for our organization. Most importantly, Chris brings the values, principles, warmth, and commitment to service that are core tenets of our work at Prime.”
Bent earned a Master of Healthcare Administration degree from the University of Minnesota. She currently serves on the board of the Women’s Health Leadership TRUST and was the past board chair for the Minnesota chapter of the American Heart Association.
Related news
Press releases
June 2, 2022
Prime Therapeutics finds $1.1 million waste reduction opportunity with medically integrated dispensing compared to central specialty pharmacy
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) analyzed…
Press releases
May 23, 2022
Prime Therapeutics’ MedDrive™ program leverages biosimilars to cut member drug expenses by 26% in one year
EAGAN, Minn. – Prime Therapeutics LLC (Prime) announced that its MedDrive™ program achieved…
Press releases
May 5, 2022
Prime Therapeutics is acquiring Magellan Rx to advance integrated specialty drug management, accelerating efforts to lower the cost of drugs and improve health outcomes
EAGAN, Minn. – Pharmacy benefit manager Prime Therapeutics LLC (Prime) on May 3…